A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly.
Trainer PJ, Newell-Price JDC, Ayuk J, Aylwin SJB, Rees A, Drake W, Chanson P, Brue T, Webb SM, Fajardo C, Aller J, McCormack AI, Torpy DJ, Tachas G, Atley L, Ryder D, Bidlingmaier M.
Trainer PJ, et al. Among authors: atley l.
Eur J Endocrinol. 2018 Aug;179(2):97-108. doi: 10.1530/EJE-18-0138. Epub 2018 May 22.
Eur J Endocrinol. 2018.
PMID: 29789410
Free PMC article.
Clinical Trial.